These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 34130217)
41. Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth. Vaaland Holmgard IC; González-Bakker A; Poeta E; Puerta A; Fernandes MX; Monti B; Fernández-Bolaños JG; Padrón JM; López Ó; Lindbäck E Org Biomol Chem; 2024 May; 22(17):3425-3438. PubMed ID: 38590227 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors. Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207 [TBL] [Abstract][Full Text] [Related]
43. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase. Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502 [TBL] [Abstract][Full Text] [Related]
44. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Ma F; Du H Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380 [TBL] [Abstract][Full Text] [Related]
45. Cyanobiphenyls: Novel H Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977 [TBL] [Abstract][Full Text] [Related]
46. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase. Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700 [TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase. Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363 [TBL] [Abstract][Full Text] [Related]
50. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation]. Luo W; Zhao YM; Tian RG; Su YB; Hong C Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin. Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699 [TBL] [Abstract][Full Text] [Related]
52. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives. Mohammadi-Khanaposhtani M; Saeedi M; Zafarghandi NS; Mahdavi M; Sabourian R; Razkenari EK; Alinezhad H; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T Eur J Med Chem; 2015 Mar; 92():799-806. PubMed ID: 25636055 [TBL] [Abstract][Full Text] [Related]
53. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis. Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911 [TBL] [Abstract][Full Text] [Related]
54. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476 [TBL] [Abstract][Full Text] [Related]
57. Donepezil-melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments. Łozińska I; Świerczyńska A; Molęda Z; Hartman AM; Hirsch AKH; Czarnocki Z Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800194. PubMed ID: 30290008 [TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents. Mostofi M; Mohammadi Ziarani G; Lashgari N Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481 [TBL] [Abstract][Full Text] [Related]